Aurora, COLORADO2 Active Studies

Diabetic Kidney Disease Clinical Trials in Aurora, COLORADO

Find 2 actively recruiting diabetic kidney disease clinical trials in Aurora, COLORADO. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
2,570
Enrolling

Recruiting Diabetic Kidney Disease Studies in Aurora

About Diabetic Kidney Disease Clinical Trials in Aurora

Diabetic kidney disease (diabetic nephropathy) is a complication of diabetes that affects the kidneys' filtering ability, potentially leading to kidney failure. It is the leading cause of end-stage kidney disease worldwide. Management includes blood sugar control, blood pressure medications, and SGLT2 inhibitors.

There are currently 2 diabetic kidney disease clinical trials recruiting participants in Aurora, COLORADO. These studies are seeking a combined 2,570 participants. Research is being sponsored by VA Office of Research and Development, University of Washington. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Kidney Disease Clinical Trials in Aurora — FAQ

Are there diabetic kidney disease clinical trials in Aurora?

Yes, there are 2 diabetic kidney disease clinical trials currently recruiting in Aurora, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What diabetic kidney disease treatments are being tested?

The 2 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic kidney disease.

Data updated March 2, 2026 from ClinicalTrials.gov